U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H30Cl2N10.2C6H12O7
Molecular Weight 897.7584
Optical Activity UNSPECIFIED
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CHLORHEXIDINE GLUCONATE

SMILES

C(CCCNC(=N)NC(=N)Nc1ccc(cc1)Cl)CCNC(=N)NC(=N)Nc2ccc(cc2)Cl.C([C@]([H])([C@]([H])([C@@]([H])([C@]([H])(C(=O)O)O)O)O)O)O.C([C@]([H])([C@]([H])([C@@]([H])([C@]([H])(C(=O)O)O)O)O)O)O

InChI

InChIKey=YZIYKJHYYHPJIB-UUPCJSQJSA-N
InChI=1S/C22H30Cl2N10.2C6H12O7/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18;2*7-1-2(8)3(9)4(10)5(11)6(12)13/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34);2*2-5,7-11H,1H2,(H,12,13)/t;2*2-,3-,4+,5-/m.11/s1

HIDE SMILES / InChI

Molecular Formula C6H12O7
Molecular Weight 196.1555
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula C22H30Cl2N10
Molecular Weight 505.4473
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment:: Description was created based on several sources, including: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019028s022lbl.pdf http://www.drugbank.ca/drugs/DB00878 http://www.wikidoc.org/index.php/Chlorhexidine_gluconate

Chlorhexidine is a broad-spectrum biocide effective against Gram-positive bacteria, Gram-negative bacteria and fungi. It is used primarily as its salts (e.g., the dihydrochloride, diacetate, and digluconate). Chlorhexidine inactivates microorganisms with a broader spectrum than other antimicrobials (e.g. antibiotics) and has a quicker kill rate than other antimicrobials (e.g. povidone-iodine). It has both bacteriostatic (inhibits bacterial growth) and bactericidal (kills bacteria) mechanisms of action, depending on its concentration. Chlorhexidine kills by disrupting the cell membrane. The most common side effects associated with chlorhexidine gluconate oral rinses are: 1) an increase in staining of teeth and other oral surfaces; 2) an increase in calculus formation; and 3) an alteration in taste perception; 4) toothache; 5) upper respiratory tract infection; and 6) headache.

Originator

Curator's Comment:: 1950s — Chlorhexidine is discovered by the Imperial Chemical Industries, Limited (Manchester, UK) while researching the synthesis of anti-malarial agents

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: bacterial cell wall
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
HIBICLENS

Approved Use

Use for the preparation of the patient's skin prior to surgery. Helps to reduce bacteria that potentially can cause skin infection.

Launch Date

2.11766395E11
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
2007 μg/mL
2.5 mg single, dental
dose: 2.5 mg
route of administration: Dental
experiment type: SINGLE
co-administered:
CHLORHEXIDINE inflammatory exudate
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
0.206 μg/g
300 mg single, oral
dose: 300 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
CHLORHEXIDINE plasma
Homo sapiens
population: UNKNOWN
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
187083.4 μg × h/mL
2.5 mg single, dental
dose: 2.5 mg
route of administration: Dental
experiment type: SINGLE
co-administered:
CHLORHEXIDINE inflammatory exudate
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
148287.6 ng × h/mL
0.2 % single, dental
dose: 0.2 %
route of administration: Dental
experiment type: SINGLE
co-administered:
CHLORHEXIDINE saliva
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
180892.9 ng × h/mL
0.2 % 1 times / day multiple, dental
dose: 0.2 %
route of administration: Dental
experiment type: MULTIPLE
co-administered:
CHLORHEXIDINE saliva
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
17%
CHLORHEXIDINE serum
Homo sapiens
population: UNKNOWN
age: UNKNOWN
sex: UNKNOWN
food status: UNKNOWN
73%
CHLORHEXIDINE saliva
Homo sapiens
population: UNKNOWN
age: UNKNOWN
sex: UNKNOWN
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
2 % 1 times / day single, topical
Recommended
Dose: 2 %, 1 times / day
Route: topical
Route: single
Dose: 2 %, 1 times / day
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
healthy, 18-64 years
n = 36
Health Status: healthy
Age Group: 18-64 years
Sex: M+F
Population Size: 36
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
Other AEs: Redness...
Other AEs:
Redness (grade 2)
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
3 % 1 times / day multiple, topical (mean)
Recommended
Dose: 3 %, 1 times / day
Route: topical
Route: multiple
Dose: 3 %, 1 times / day
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
healthy, 18-79 years
n = 204
Health Status: healthy
Age Group: 18-79 years
Sex: M+F
Population Size: 204
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
Disc. AE: Papule, Erythema...
AEs leading to
discontinuation/dose reduction:
Papule
Erythema (grade 2)
Edema (grade 1)
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
3 % 1 times / day multiple, topical (mean)
Recommended
Dose: 3 %, 1 times / day
Route: topical
Route: multiple
Dose: 3 %, 1 times / day
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
healthy, 22-60 years
n = 23
Health Status: healthy
Age Group: 22-60 years
Sex: M+F
Population Size: 23
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
Disc. AE: Burning sensation, Petechial rash...
AEs leading to
discontinuation/dose reduction:
Burning sensation (grade 1)
Petechial rash (grade 1)
Scab
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
1.5 oz 1 times / day single, oral (mean)
Studied dose
Dose: 1.5 oz, 1 times / day
Route: oral
Route: single
Dose: 1.5 oz, 1 times / day
Sources:
healthy, child
n = 1
Health Status: healthy
Age Group: child
Population Size: 1
Sources:
Other AEs: Distress epigastric, Nausea...
Other AEs:
Distress epigastric
Nausea
Alcohol intoxication
Sources:
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Other AEs: Toothache, Upper respiratory tract infection...
Other AEs:
Toothache (50.7%)
Upper respiratory tract infection (28.4%)
Headache (27.1%)
Sinusitis (13.8%)
Influenza-like symptoms (7.6%)
Back pain (6.7%)
Tooth disorder (6.2%)
Bronchitis (6.2%)
Abscess (5.8%)
Pain (4.9%)
Allergy (4%)
Myalgia (4%)
Gum hyperplasia (3.6%)
Pharyngitis (3.6%)
Arthralgia (3.1%)
Dysmenorrhea (3.1%)
Dyspepsia (3.1%)
Rhinitis (2.7%)
Coughing (2.7%)
Arthrosis (2.7%)
Hypertension (2.2%)
Stomatitis ulcerative (2.2%)
Tendinitis (2.2%)
Sources:
AEs

AEs

AESignificanceDosePopulation
Redness grade 2
2 % 1 times / day single, topical
Recommended
Dose: 2 %, 1 times / day
Route: topical
Route: single
Dose: 2 %, 1 times / day
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
healthy, 18-64 years
n = 36
Health Status: healthy
Age Group: 18-64 years
Sex: M+F
Population Size: 36
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
Papule Disc. AE
3 % 1 times / day multiple, topical (mean)
Recommended
Dose: 3 %, 1 times / day
Route: topical
Route: multiple
Dose: 3 %, 1 times / day
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
healthy, 18-79 years
n = 204
Health Status: healthy
Age Group: 18-79 years
Sex: M+F
Population Size: 204
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
Edema grade 1
Disc. AE
3 % 1 times / day multiple, topical (mean)
Recommended
Dose: 3 %, 1 times / day
Route: topical
Route: multiple
Dose: 3 %, 1 times / day
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
healthy, 18-79 years
n = 204
Health Status: healthy
Age Group: 18-79 years
Sex: M+F
Population Size: 204
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
Erythema grade 2
Disc. AE
3 % 1 times / day multiple, topical (mean)
Recommended
Dose: 3 %, 1 times / day
Route: topical
Route: multiple
Dose: 3 %, 1 times / day
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
healthy, 18-79 years
n = 204
Health Status: healthy
Age Group: 18-79 years
Sex: M+F
Population Size: 204
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
Scab Disc. AE
3 % 1 times / day multiple, topical (mean)
Recommended
Dose: 3 %, 1 times / day
Route: topical
Route: multiple
Dose: 3 %, 1 times / day
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
healthy, 22-60 years
n = 23
Health Status: healthy
Age Group: 22-60 years
Sex: M+F
Population Size: 23
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
Burning sensation grade 1
Disc. AE
3 % 1 times / day multiple, topical (mean)
Recommended
Dose: 3 %, 1 times / day
Route: topical
Route: multiple
Dose: 3 %, 1 times / day
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
healthy, 22-60 years
n = 23
Health Status: healthy
Age Group: 22-60 years
Sex: M+F
Population Size: 23
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
Petechial rash grade 1
Disc. AE
3 % 1 times / day multiple, topical (mean)
Recommended
Dose: 3 %, 1 times / day
Route: topical
Route: multiple
Dose: 3 %, 1 times / day
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
healthy, 22-60 years
n = 23
Health Status: healthy
Age Group: 22-60 years
Sex: M+F
Population Size: 23
Sources: Page: nda/2005/21669s000_MedR.pdf - p.83
Alcohol intoxication
1.5 oz 1 times / day single, oral (mean)
Studied dose
Dose: 1.5 oz, 1 times / day
Route: oral
Route: single
Dose: 1.5 oz, 1 times / day
Sources:
healthy, child
n = 1
Health Status: healthy
Age Group: child
Population Size: 1
Sources:
Distress epigastric
1.5 oz 1 times / day single, oral (mean)
Studied dose
Dose: 1.5 oz, 1 times / day
Route: oral
Route: single
Dose: 1.5 oz, 1 times / day
Sources:
healthy, child
n = 1
Health Status: healthy
Age Group: child
Population Size: 1
Sources:
Nausea
1.5 oz 1 times / day single, oral (mean)
Studied dose
Dose: 1.5 oz, 1 times / day
Route: oral
Route: single
Dose: 1.5 oz, 1 times / day
Sources:
healthy, child
n = 1
Health Status: healthy
Age Group: child
Population Size: 1
Sources:
Sinusitis 13.8%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Hypertension 2.2%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Stomatitis ulcerative 2.2%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Tendinitis 2.2%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Arthrosis 2.7%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Coughing 2.7%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Rhinitis 2.7%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Headache 27.1%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Upper respiratory tract infection 28.4%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Arthralgia 3.1%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Dysmenorrhea 3.1%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Dyspepsia 3.1%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Gum hyperplasia 3.6%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Pharyngitis 3.6%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Allergy 4%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Myalgia 4%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Pain 4.9%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Abscess 5.8%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Toothache 50.7%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Bronchitis 6.2%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Tooth disorder 6.2%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Back pain 6.7%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
Influenza-like symptoms 7.6%
2.5 mg 3 times / month multiple, subgingival
Recommended
unhealthy, mean age 47 years
n = 225
PubMed

PubMed

TitleDatePubMed
The effect of chlorhexidine irrigation of the bladder in the rat.
1975 Oct
Further studies on effects of irrigation solutions on rat bladders.
1976 Dec
Nephrotoxic and hepatotoxic effects of triclosan and chlorhexidine in rats.
1977 Oct
[Disturbances of taste from oral disinfectants (author's transl)].
1978 Oct
Some toxic effects of lead, other metals and antibacterial agents on the nervous system--animal experiment models.
1984
Bradycardia associated with chlorhexidine spray.
1989 Jun
Combined effects of Zn(2+)-chlorhexidine and Zn(2+)-cetylpyridinium chloride on caries incidence in partially desalivated rats.
1991 Aug
Effects of chlorhexidine diacetate on Candida albicans, C. glabrata and Saccharomyces cerevisiae.
1992 Apr
[Anaphylactic shock with ventricular fibrillation induced by chlorhexidine].
1992 Mar
Spermicides: anti-HIV activity and cytotoxicity in vitro.
1993 Feb
The activity of candidate virucidal agents, low pH and genital secretions against HIV-1 in vitro.
1995 Jul-Aug
The effectiveness and side effects of 0.1% and 0.2% chlorhexidine mouthrinses: a clinical study.
1998 Jul
Clinical and pathological changes in the knee after accidental chlorhexidine irrigation during arthroscopy. Case reports and review of the literature.
1998 May
6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis.
1998 Sep
Severe anaphylaxis after a chlorhexidine bath.
1999 May
Developing a dynamic pharmacophore model for HIV-1 integrase.
2000 Jun 1
Chlorhexidine and taste. Influence of mouthwashes concentration and of rinsing time.
2000 May
Probing depth changes following 2 years of periodontal maintenance therapy including adjunctive controlled release of chlorhexidine.
2003 Apr
Effects of a chlorhexidine gluconate-containing mouthwash on the vitality and antimicrobial susceptibility of in vitro oral bacterial ecosystems.
2003 Aug
[Contact sensitization to pharmaceutic aids in dermatologic cosmetic and external use preparations].
2004 May
Chlorhexidine induces DNA damage in rat peripheral leukocytes and oral mucosal cells.
2004 Oct
Remineralisation of carious enamel lesions after application of a CHX/F-mouthrinse compared with sole CHX- and placebo-application.
2006
Chlorhexidine in urethral gel: does it cause pain at flexible cystoscopy?
2006 Apr
Short-term side effects of 0.2% alcohol-free chlorhexidine mouthrinse used as an adjunct to non-surgical periodontal treatment: a double-blind clinical study.
2006 Mar
Chemoenzymatic synthesis and antimicrobial and haemolytic activities of amphiphilic bis(phenylacetylarginine) derivatives.
2006 Oct
Cysticidal effect on acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine.
2007 Jul
Adverse events associated with chlorhexidine use: results from the Department of Veterans Affairs Dental Diabetes Study.
2008 Feb
[Ultrastructure study of pathogen of acanthamoeba keratitis].
2008 Nov
Chlorhexidine-induced apoptosis or necrosis in L929 fibroblasts: A role for endoplasmic reticulum stress.
2009 Jan 15
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.
2011 Jul 14
Food components with anticaries activity.
2012 Apr
Identification and characterization of inhibitors of the aminoglycoside resistance acetyltransferase Eis from Mycobacterium tuberculosis.
2012 Jan 2
Cytotoxicity and genotoxicity of chlorhexidine on macrophages in vitro.
2014 Apr
Patents

Sample Use Guides

Recommended use is twice daily oral rinsing for 30 seconds, morning and evening after tooth brushing. Usual dosage is 15 ml (1 tablespoon) of undiluted Chlorhexidine gluconate oral rinse. Prophylaxis intervals - no longer than six months.
Route of Administration: Topical
In Vitro Use Guide
Curator's Comment:: Chlorhexidine caused significant decreases in both total anaerobe and total aerobe/facultative anaerobe counts (P < 0.05), together with lesser decreases in gram-negative anaerobes.
Minimum bactericidal concentrations are different for different bacterial strains (3.9-83.3 mg/l).
Substance Class Chemical
Created
by admin
on Fri Jun 25 21:14:14 UTC 2021
Edited
by admin
on Fri Jun 25 21:14:14 UTC 2021
Record UNII
MOR84MUD8E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CHLORHEXIDINE GLUCONATE
MART.   ORANGE BOOK   USAN   USP   VANDF   WHO-DD  
USAN  
Official Name English
CHLORHEXIDINE GLUCONATE COMPONENT OF CHLORAPREP
Common Name English
CHLORHEXIDINE GLUCONATE [VANDF]
Common Name English
1,1'-HEXAMETHYLENEBIS(5-(P-CHLOROPHENYL)BIGUANIDE) DI-D-GLUCONATE
Common Name English
PERIOGARD
Brand Name English
MICRODERM
Brand Name English
EXIDINE
Brand Name English
CHLORHEXIDINE GLUCONATE [MART.]
Common Name English
CHLORHEXIDINE GLUCONATE [USP]
Common Name English
CHLORHEXIDINE DIGLUCONATE SOLUTION
EP  
Common Name English
PERIOCHIP
Brand Name English
CHLORHEXIDINE GLUCONATE COMPONENT OF AVAGARD
Common Name English
BIOSCRUB
Brand Name English
CHLORHEXIDINE DIGLUCONATE [INCI]
Common Name English
AVAGARD COMPONENT CHLORHEXIDINE GLUCONATE
Common Name English
HIBICLENS
Brand Name English
2,4,11,13-TETRAAZATETRADECANEDIIMIDAMIDE, N,N''-BIS(4-CHLOROPHENYL)-3,12-DIIMINO-, DI-D-GLUCONATE
Common Name English
BRIAN CARE
Brand Name English
READYPREP CHG
Brand Name English
CHLORHEXIDINE D-DIGLUCONATE
MI  
Common Name English
CHLORHEXIDINE D-DIGLUCONATE [MI]
Common Name English
CHLORAPREP COMPONENT CHLORHEXIDINE GLUCONATE
Common Name English
CHG SCRUB
Brand Name English
PERIDEX
Brand Name English
PREVACARE
Brand Name English
PHARMASEAL SCRUB CARE
Brand Name English
SOLUPREP COMPONENT CHLORHEXIDINE GLUCONATE
Brand Name English
NSC-753971
Code English
CHLORHEXIDINE GLUCONATE [USAN]
Common Name English
STERI-STAT
Brand Name English
CHLORHEXIDINE DIGLUCONATE
INCI  
INCI  
Official Name English
CIDA-STAT
Brand Name English
DYNA-HEX
Brand Name English
CHLORHEXIDINE GLUCONATE [ORANGE BOOK]
Common Name English
HIBISTAT
Brand Name English
CHLORHEXIDINE GLUCONATE COMPONENT OF SOLUPREP
Brand Name English
CHLORHEXIDINE GLUCONATE [JAN]
Common Name English
CHLORHEXIDINE DIGLUCONATE SOLUTION [EP MONOGRAPH]
Common Name English
CHLORHEXIDINE GLUCONATE [WHO-DD]
Common Name English
Classification Tree Code System Code
EPA PESTICIDE CODE 45504
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
FDA ORPHAN DRUG 13086
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
NCI_THESAURUS C28394
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
Code System Code Type Description
EPA CompTox
18472-51-0
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
PRIMARY
DRUG BANK
DBSALT000023
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
PRIMARY
ECHA (EC/EINECS)
242-354-0
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
PRIMARY
FDA UNII
MOR84MUD8E
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
PRIMARY
MERCK INDEX
M3362
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
PRIMARY Merck Index
PUBCHEM
29089
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
PRIMARY
EVMPD
SUB01215MIG
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
PRIMARY
RXCUI
20791
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
PRIMARY RxNorm
CAS
18472-51-0
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
PRIMARY
NCI_THESAURUS
C47974
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
PRIMARY
MESH
C010882
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
PRIMARY
ChEMBL
CHEMBL790
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
PRIMARY
EVMPD
SUB11810MIG
Created by admin on Fri Jun 25 21:14:15 UTC 2021 , Edited by admin on Fri Jun 25 21:14:15 UTC 2021
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY